Skip to main content
Sign In

Division Head

Oliver Eickelberg, MD
Head of the Division of Pulmonary Sciences and Critical Care Medicine

Oliver Eickelberg, MD, is the incoming Division Head for Pulmonary Sciences and Critical Care Medicine at the University of Colorado. Dr. Eickelberg received his MD from the Universities of Basel, Switzerland, and Lubeck, Germany. He did post-doctoral training at Yale University and junior faculty at the University of Giessen. He has been a member of the American Thoracic Society (ATS) since 2001 and served on its Program Committee (2005-2009) and the Planning Committee (current) of RCMB. Currently, Dr. Eickelberg serves as an Associate Editor of the American Journal of Respiratory and Critical Care Medicine (AJRCCM), PLoS One, and Scientific Reports.

Before coming to Colorado, Oliver was Chairman of the Comprehensive Pneumology Center Munich, a joint initiative of the Ludwig-Maximilians-University, the Asklepios Klinik Gauting, and the Helmholtz Zentrum Munich. He also served as director of the Institute of Lung Biology and Disease (iLBD) at the Helmholtz Zentrum Munich and Vice Chairman of the German Center of Lung Research. Oliver Eickelberg’s research interests focus on the mechanisms of lung injury and repair in idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). He investigates signaling mechanisms that initiate and perpetuate the processes of myofibroblast activation and epithelial-mesenchymal transition. Dr. Eickelberg has a long-standing interest in the molecular mechanisms and therapeutic advances of IPF and COPD, and has served on a number of committees and institutions for this purpose. He is Co-Director of the Foundation (“Stiftung”) AtemWeg, a non-profit foundation working for the cure of chronic lung disease and raising public awareness about people suffering from these diseases.

Oliver Eickelberg has a keen interest in raising future leaders in respiratory medicine. He is founding director of two graduate programs solely dedicated to respiratory medicine in Germany, “Molecular Biology and Medicine of the Lung (MBML)” and “Lung Biology and Disease (LBD)” in Giessen and Munich, respectively.​